This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2015
  • /
  • 11
  • /
  • Zerbaxa (ceftolozane + tazobactam) is launched in ...
Drug news

Zerbaxa (ceftolozane + tazobactam) is launched in the UK-Merck Inc.

Read time: 1 mins
Last updated:24th Nov 2015
Published:24th Nov 2015
Source: Pharmawand

Zerbaxa (ceftolozane + tazobactam) from Merck Inc. is launched in the United Kingdom to treat complicated intra-abdominal infections, acute pyelonephritis and complicated urinary tract infections.

Comment: The combination was approved in the US in December 2014 and was EU approved in September 2015.The drug was originally developed by Cubist Pharma which was acquired by Merck Inc.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.